Herviou, Laurie
Kassambara, Alboukadel
Boireau, Stéphanie
Robert, Nicolas
Requirand, Guilhem
Müller-Tidow, Carsten
Vincent, Laure
Seckinger, Anja
Goldschmidt, Hartmut
Cartron, Guillaume
Hose, Dirk
Cavalli, Giacomo
Moreaux, Jerome
Funding for this research was provided by:
Labex EpiGenMed (ANR-10-LABX-12-01)
Institut National Du Cancer (2012-109/087437 and PLBIO15-256)
Conseil Régional Languedoc-Roussillon (R14026FF)
Fondation de France (201400047510)
SIRIC Montpellier (INCa-DGOS-Inserm 6045)
Article History
Received: 9 April 2018
Accepted: 24 September 2018
First Online: 3 October 2018
Ethics approval and consent to participate
: BM of patients presenting with previously untreated MM at the university hospital of Montpellier was obtained after patients’ written informed consent in accordance with the Declaration of Helsinki and agreement of the Montpellier University Hospital Centre for Biological Resources (DC-2008-417).
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.